Continuous heart rate monitoring in atrial fibrillation with multispectral photoplethysmography

Heart attacks and strokes account for more than four out of every five Cardiovascular Disease (CVD) deaths, with one-third occurring before age 70 years. Atrial fibrillation (AF), a common cause of ischemic strokes, can significantly reduce mortality rates through continuous monitoring, timely diagnosis, accurate confirmation, and early prognosis. This can be achieved by employing Multi-Spectral Photoplethysmography (MSPPG) technology as an alternative diagnostic tool to Electrocardiography (ECG). This investigation is implemented by determining the Heart Rate (HR) of AF-affected patients using a developed MSPPG-based wrist-worn device, keeping ECG as a standard gold reference. The Multispectral-based wrist-worn wearable Photoplethysmography device employs an optical bio-sensing, integrated BIOFY sensor to acquire the MSPPG signals using two green (526 nm), one red (660 nm) and one infrared (950 nm) LED and two photodetectors (Broadband detector, IR-cut detector). The MSPPG signals acquired using a microcontroller unit are stored in an On-device storage system simultaneously in the IoT Platform. Statistical analysis techniques were employed to compare the HR detected using the MSPPG technique with the HR measured from the gold-standard ECG. The accuracy paves the way for implementing the proposed MSPPG technology in detecting AF conditions in terms of HR, further laying the foundation for earlier detection of AF. Wearable PPG-based devices face a significant issue of motion artifacts that can be overcome using the MSPPG technique. The research advancements can potentially increase the accessibility of HR monitoring in AF patients, conveniently integrating into daily routines without restricting day-to-day activities.